dihydroethidium has been researched along with Muscle Relaxation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Faraci, FM; Gunnett, CA; Heistad, DD | 1 |
| Anstadt, MP; Caldwell, RW; Ergul, A; Harris, AK; Hutchinson, J; Johansen, JS; Rahimi, A; Rhim, E; Strømhaug, C; Tawfik, A; Wells, B | 1 |
1 trial(s) available for dihydroethidium and Muscle Relaxation
| Article | Year |
|---|---|
Vascular dysfunction of venous bypass conduits is mediated by reactive oxygen species in diabetes: role of endothelin-1.
Topics: Blotting, Western; Coronary Artery Bypass; Coronary Vessels; Diabetes Mellitus; Dose-Response Relationship, Drug; Endothelin-1; Ethidium; Female; Fluorescent Dyes; Humans; Male; Microscopy, Confocal; Middle Aged; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; NADPH Oxidases; Reactive Oxygen Species | 2005 |
1 other study(ies) available for dihydroethidium and Muscle Relaxation
| Article | Year |
|---|---|
Interleukin-10 protects nitric oxide-dependent relaxation during diabetes: role of superoxide.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Allopurinol; Animals; Arteries; Blood Glucose; Citric Acid; Diabetes Mellitus, Experimental; Endothelium, Vascular; Enzyme Inhibitors; Female; Fluorescent Dyes; Interleukin-10; Male; Mice; Mice, Inbred C57BL; Microscopy, Confocal; Muscle Relaxation; Muscle, Smooth, Vascular; Nitric Oxide; Nitroprusside; Phenanthridines; Polyethylene Glycols; Superoxide Dismutase; Superoxides; Vasoconstrictor Agents; Xanthine Oxidase | 2002 |